STOCK TITAN

[SCHEDULE 13G/A] uniQure N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Vestal Point Capital, LP and Ryan Wilder reported beneficial ownership of 3,700,000 ordinary shares of uniQure N.V., representing 6.8% of the outstanding class. The shares are directly held by a Vestal Point-managed fund and a managed account; Mr. Wilder is the Chief Investment Officer and managing partner of the investment manager and reports shared voting and dispositive power over the shares. The percent calculation uses 54,748,496 ordinary shares outstanding as of May 6, 2025. The filing states the holdings were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Vestal Point Capital, LP e Ryan Wilder hanno dichiarato la titolarità beneficiaria di 3.700.000 azioni ordinarie di uniQure N.V., pari al 6,8% delle azioni della classe in circolazione. Le azioni sono detenute direttamente da un fondo gestito da Vestal Point e da un conto gestito; il sig. Wilder è Chief Investment Officer e managing partner della società di gestione e dichiara di avere poteri condivisi di voto e di disposizione sulle azioni. Il calcolo percentuale si basa su 54.748.496 azioni ordinarie in circolazione al 6 maggio 2025. La comunicazione afferma che le partecipazioni sono state acquisite nell'ambito ordinario dell'attività e non con l'intento di modificare o influenzare il controllo dell'emittente.

Vestal Point Capital, LP y Ryan Wilder informaron la propiedad beneficiaria de 3.700.000 acciones ordinarias de uniQure N.V., lo que representa el 6,8% de la clase en circulación. Las acciones están en poder directo de un fondo gestionado por Vestal Point y de una cuenta administrada; el Sr. Wilder es Director de Inversiones y socio gerente del gestor y declara tener poderes compartidos de voto y disposición sobre las acciones. El porcentaje se calcula sobre 54.748.496 acciones ordinarias en circulación al 6 de mayo de 2025. La presentación indica que las participaciones se adquirieron en el curso normal del negocio y no con el propósito de cambiar o influir en el control del emisor.

Vestal Point Capital, LP와 라이언 와일더(Ryan Wilder)는 uniQure N.V. 보통주 3,700,000주(발행 주식의 6.8%)의 사실상 소유를 보고했습니다. 해당 주식은 Vestal Point가 운용하는 펀드와 운용 계좌에서 직접 보유하고 있으며, 와일더 씨는 투자운용사의 최고투자책임자(CIO) 겸 매니징 파트너로서 주식에 대한 공동 의결권 및 처분권을 보고했습니다. 비율 계산은 2025년 5월 6일 기준 발행된 보통주 54,748,496주를 사용했습니다. 제출 문서에는 보유 지분이 영업의 정상적인 범위에서 취득됐으며 발행회사의 지배를 변경하거나 영향력을 행사할 목적은 없었다고 명시되어 있습니다.

Vestal Point Capital, LP et Ryan Wilder ont déclaré la propriété bénéficiaire de 3 700 000 actions ordinaires de uniQure N.V., représentant 6,8 % de la classe en circulation. Les actions sont détenues directement par un fonds géré par Vestal Point et par un compte géré ; M. Wilder est directeur des investissements (CIO) et associé gérant du gestionnaire d'actifs et déclare disposer de pouvoirs partagés de vote et de disposition sur ces actions. Le calcul du pourcentage utilise 54 748 496 actions ordinaires en circulation au 6 mai 2025. Le dossier indique que les positions ont été acquises dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Vestal Point Capital, LP und Ryan Wilder meldeten den wirtschaftlichen Eigentum an 3.700.000 Stammaktien von uniQure N.V., was 6,8 % der ausstehenden Aktien dieser Klasse entspricht. Die Aktien werden direkt von einem von Vestal Point verwalteten Fonds und einem verwalteten Konto gehalten; Herr Wilder ist Chief Investment Officer und Managing Partner des Investmentmanagers und gibt an, über die Aktien gemeinsam Stimm- und Verfügungsrechte zu besitzen. Die Prozentangabe bezieht sich auf 54.748.496 ausstehende Stammaktien zum 6. Mai 2025. Die Einreichung erklärt, dass die Bestände im normalen Geschäftsverlauf erworben wurden und nicht zum Zweck der Änderung oder Beeinflussung der Kontrolle des Emittenten.

Positive
  • Disclosure of a material stake (3,700,000 shares, 6.8%) provides transparency to the market
  • Holdings reported as held in the ordinary course and not for control, allowing treatment as a passive investor under Schedule 13G
Negative
  • None.

Insights

TL;DR: A 6.8% disclosed stake by an investment manager signals a meaningful position but is presented as non-control and held in the ordinary course.

The filing discloses that Vestal Point Capital, through a fund and account it manages, holds 3.7 million uniQure ordinary shares, equal to 6.8% of shares outstanding based on the companys May 6, 2025 share count. Shared voting and dispositive power are reported, with no sole voting or dispositive power. The statement emphasizes the positions were not acquired to influence control. For investors, a >5% ownership can lead to increased attention and potential engagement, but the filing contains no plans or proposals and does not indicate coordinated action beyond standard investment activity.

TL;DR: Reporting is standard for Schedule 13G/A; disclosure shows material ownership but affirms non-control intent.

The disclosure complies with Schedule 13G/A conventions: it identifies the reporting persons, their roles, the business address, and the exact share and voting/dispositive breakdowns. The certification states the holdings are in the ordinary course and not intended to change control, which preserves the Schedule 13G filing status rather than a more active Schedule 13D. This distinction matters for governance watchers because it suggests passive ownership absent further filings or public statements.

Vestal Point Capital, LP e Ryan Wilder hanno dichiarato la titolarità beneficiaria di 3.700.000 azioni ordinarie di uniQure N.V., pari al 6,8% delle azioni della classe in circolazione. Le azioni sono detenute direttamente da un fondo gestito da Vestal Point e da un conto gestito; il sig. Wilder è Chief Investment Officer e managing partner della società di gestione e dichiara di avere poteri condivisi di voto e di disposizione sulle azioni. Il calcolo percentuale si basa su 54.748.496 azioni ordinarie in circolazione al 6 maggio 2025. La comunicazione afferma che le partecipazioni sono state acquisite nell'ambito ordinario dell'attività e non con l'intento di modificare o influenzare il controllo dell'emittente.

Vestal Point Capital, LP y Ryan Wilder informaron la propiedad beneficiaria de 3.700.000 acciones ordinarias de uniQure N.V., lo que representa el 6,8% de la clase en circulación. Las acciones están en poder directo de un fondo gestionado por Vestal Point y de una cuenta administrada; el Sr. Wilder es Director de Inversiones y socio gerente del gestor y declara tener poderes compartidos de voto y disposición sobre las acciones. El porcentaje se calcula sobre 54.748.496 acciones ordinarias en circulación al 6 de mayo de 2025. La presentación indica que las participaciones se adquirieron en el curso normal del negocio y no con el propósito de cambiar o influir en el control del emisor.

Vestal Point Capital, LP와 라이언 와일더(Ryan Wilder)는 uniQure N.V. 보통주 3,700,000주(발행 주식의 6.8%)의 사실상 소유를 보고했습니다. 해당 주식은 Vestal Point가 운용하는 펀드와 운용 계좌에서 직접 보유하고 있으며, 와일더 씨는 투자운용사의 최고투자책임자(CIO) 겸 매니징 파트너로서 주식에 대한 공동 의결권 및 처분권을 보고했습니다. 비율 계산은 2025년 5월 6일 기준 발행된 보통주 54,748,496주를 사용했습니다. 제출 문서에는 보유 지분이 영업의 정상적인 범위에서 취득됐으며 발행회사의 지배를 변경하거나 영향력을 행사할 목적은 없었다고 명시되어 있습니다.

Vestal Point Capital, LP et Ryan Wilder ont déclaré la propriété bénéficiaire de 3 700 000 actions ordinaires de uniQure N.V., représentant 6,8 % de la classe en circulation. Les actions sont détenues directement par un fonds géré par Vestal Point et par un compte géré ; M. Wilder est directeur des investissements (CIO) et associé gérant du gestionnaire d'actifs et déclare disposer de pouvoirs partagés de vote et de disposition sur ces actions. Le calcul du pourcentage utilise 54 748 496 actions ordinaires en circulation au 6 mai 2025. Le dossier indique que les positions ont été acquises dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Vestal Point Capital, LP und Ryan Wilder meldeten den wirtschaftlichen Eigentum an 3.700.000 Stammaktien von uniQure N.V., was 6,8 % der ausstehenden Aktien dieser Klasse entspricht. Die Aktien werden direkt von einem von Vestal Point verwalteten Fonds und einem verwalteten Konto gehalten; Herr Wilder ist Chief Investment Officer und Managing Partner des Investmentmanagers und gibt an, über die Aktien gemeinsam Stimm- und Verfügungsrechte zu besitzen. Die Prozentangabe bezieht sich auf 54.748.496 ausstehende Stammaktien zum 6. Mai 2025. Die Einreichung erklärt, dass die Bestände im normalen Geschäftsverlauf erworben wurden und nicht zum Zweck der Änderung oder Beeinflussung der Kontrolle des Emittenten.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Vestal Point Capital, LP
Signature:/s/ Ryan Wilder
Name/Title:By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Date:08/14/2025
Ryan Wilder
Signature:/s/ Ryan Wilder
Name/Title:Ryan Wilder, Individually
Date:08/14/2025

FAQ

How many uniQure (QURE) shares does Vestal Point Capital report owning?

The filing reports 3,700,000 ordinary shares, representing 6.8% of the class.

Who else is named on the Schedule 13G/A filing for QURE?

The filing names Vestal Point Capital, LP as the investment manager and Ryan Wilder (CIO and Managing Partner) as an individual reporting person.

What voting and dispositive power is reported over the QURE shares?

The reporting persons state 0 sole voting power and 3,700,000 shared voting and shared dispositive power; sole dispositive power is 0.

What share count was used to calculate the 6.8% ownership for QURE?

The percentage is based on 54,748,496 ordinary shares outstanding as of May 6, 2025, per the company's quarterly report.

Does the filing indicate Vestal Point intends to influence control of uniQure?

No. The certification states the shares were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Uniqure

NASDAQ:QURE

QURE Rankings

QURE Latest News

QURE Latest SEC Filings

QURE Stock Data

784.60M
51.08M
6.08%
92.04%
15.74%
Biotechnology
Pharmaceutical Preparations
Link
Netherlands
AMSTERDAM